TheProfitWatch

LYEL - Lyell Immunopharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.86 0.44 (2.61%) --- --- --- 0.0 (0.0%) 0.34 (2.0%) --- 0.0 (0.0%)

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.89
Diluted EPS:
-2.89
Basic P/E:
-5.9862
Diluted P/E:
-5.9862
RSI(14) 1m:
14.29
VWAP:
17.36
RVol:
0.2151

Events

Period Kind Movement Occurred At

Related News